Search Results - "Gouget, Hélène"

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    UPLC–MS/MS method for the simultaneous quantification of bictegravir and 13 others antiretroviral drugs plus cobicistat and ritonavir boosters in human plasma by Gouget, Hélène, Noé, Gaëlle, Barrail-Tran, Aurélie, Furlan, Valérie

    “…•New quantification method for 13 antiretroviral drugs with most recent bictegravir and two booster cobicistat and ritonavir.•Sensitive and rapid ultra-high…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Pharmacokinetics and tissue distribution of tenofovir, emtricitabine and dolutegravir in mice by Labarthe, Laura, Gelé, Thibaut, Gouget, Hélène, Benzemrane, Mariam-Sarah, Le Calvez, Pauline, Legrand, Nicolas, Lambotte, Olivier, Le Grand, Roger, Bourgeois, Christine, Barrail-Tran, Aurélie

    Published in Journal of antimicrobial chemotherapy (31-03-2022)
    “…Abstract Background Studies of antiretroviral drug (ARV) tissue distribution in preclinical models, such as mice, are key to understanding viral persistence…”
    Get full text
    Journal Article
  4. 4

    Whole-body distribution of tenofovir, emtricitabine and dolutegravir in non-human primates by Gelé, Thibaut, Gouget, Hélène, Dimant, Nastasia, Furlan, Valérie, Collins, Jon, Scholz, Erin M B, Parry, Chris M, Le Grand, Roger, Lambotte, Olivier, Desjardins, Delphine, Barrail-Tran, Aurélie

    Published in Journal of antimicrobial chemotherapy (03-09-2024)
    “…Abstract Background One major barrier to HIV cure is the persistence of virus, possibly linked to an insufficient antiretroviral drug (ARV) distribution into…”
    Get full text
    Journal Article
  5. 5

    Characteristics of Dolutegravir and Bictegravir Plasma Protein Binding: a First Approach for the Study of Pharmacologic Sanctuaries by Gelé, Thibaut, Gouget, Hélène, Furlan, Valérie, Becker, Pierre-Hadrien, Taburet, Anne-Marie, Lambotte, Olivier, Barrail-Tran, Aurélie

    Published in Antimicrobial agents and chemotherapy (20-10-2020)
    “…This study aimed to characterize dolutegravir (DTG) and bictegravir (BIC) binding. They had a preferential binding to human serum albumin (HSA) with two…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Pharmacological Validation of Long-Term Treatment with Antiretroviral Drugs in a Model of SIV-Infected Non-Human Primates by Gelé, Thibaut, Gouget, Hélène, Dereuddre-Bosquet, Nathalie, Furlan, Valérie, Le Grand, Roger, Lambotte, Olivier, Desjardins, Delphine, Barrail-Tran, Aurélie

    Published in Pharmaceutics (25-10-2022)
    “…The development of animal models undergoing long-term antiretroviral treatment (ART) makes it possible to understand a number of immunological, virological,…”
    Get full text
    Journal Article